Jenny Byrne - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Jenny Byrne

This paper was not found in any repository, but could be made available legally by the author.

2024 Guillermo Ortí

ORCID

, Luuk Gras, Linda Koster, Aleksander Kulagin

ORCID

, Jenny Byrne

ORCID

, Jane F. Apperley, Kazimierz Halaburda

ORCID

, Igor Wolfgang Blau, Andrew Clark, Nicolaus Kröger

ORCID

, Laimonas Griskevicius, Kristina Carlson

ORCID

, Matthew Collin, Adrian Bloor, Anna Maria Raiola and 12 other authors

Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)

Upload

This paper is made freely available by the publisher.

2023 Claire N. Harrison

ORCID

, Jyoti Nangalia

ORCID

, Rebecca Boucher

ORCID

, Aimee Jackson, Christina Yap

ORCID

, Jennifer O'Sullivan, Sonia Fox, Isaak Ailts

ORCID

, Amylou C. Dueck

ORCID

, Holly L. Geyer, Ruben A. Mesa

ORCID

, William G. Dunn

ORCID

, Eugene Nadezhdin, Natalia Curto-Garcia, Anna Green and 18 other authors

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Download from doi.org

This paper is made freely available by the publisher.

2020 Charles Craddock

ORCID

, Aimee Jackson, Justin Loke

ORCID

, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew

ORCID

, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria Gilleece

ORCID

, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley and 12 other authors

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Download from doi.org

This paper is made freely available by the publisher.

Zinaida Peric, Myriam Labopin, Christophe Peczynski

ORCID

, Emmanuelle Polge, Jan Cornelissen, Ben Carpenter, Mike Potter, Ram Malladi, Jenny Byrne

ORCID

, Harry Schouten, Nathalie Fegueux, Gerard Socié

ORCID

, Montserrat Rovira, Jurgen Kuball

ORCID

, Maria Gilleece

ORCID

and 3 other authors

Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT

Download from www.nature.com

This paper is made freely available by the publisher.

Chloe Anthias, Jane Apperley

ORCID

, Adrian Bloor, Jennifer Byrne

ORCID

, Matthew Collin

ORCID

, Charles Crawley, Charles Craddock, Damian Finnegan, Maria Gilleece

ORCID

ORCID

, Ann Hunter, Hannah Hunter, Mickey Koh, Stephen Mackinnon, Ram Malladi and 15 other authors

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

G. A. Horne

ORCID

, J. Stobo

ORCID

, C. Kelly, A. Mukhopadhyay, A. L. Latif, J. Dixon-Hughes, L. McMahon, P. Cony-Makhoul, J. Byrne

ORCID

, G. Smith, S. Koschmieder

ORCID

, T. H. BrÜmmendorf, P. Schafhausen, P. Gallipoli

ORCID

, F. Thomson and 8 other authors

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 Aleksandar Radujkovic, Koc Yener, Sascha Dietrich, Henric-Jan Blok, Arnon Nagler, Francis Ayuketang Ayuk, Jürgen Finke, Johanna Tischer, Jiri Mayer, Federica Sorà, Jakob R. Passweg, Jenny L. Byrne

ORCID

ORCID

, Joan Hendrik Veelken, Gerard Socié and 13 other authors

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

Upload

This paper was not found in any repository, but could be made available legally by the author.

Jenny Byrne

ORCID

, Rachel Pearce, Julia Perry, C. Crawley, Graham Jackson

Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Abdullah Pandor, Matt Stevenson

ORCID

, John Stevens, Marrissa Martyn-St James, Jean Hamilton, Jenny Byrne

ORCID

, Claudius Rudin, Andrew Rawdin, Ruth Wong

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Upload

This paper is available in a repository.

2017 Richard E. Clark, Fotios Polydoros, Jane F. Apperley, Dragana Milojkovic, Christopher Pocock, Graeme Smith, Jenny L. Byrne

ORCID

, Hugues de Lavallade, Stephen G. O'Brien, Tony Coffey, Letizia Foroni, Mhairi Copland

De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial

Download from hdl.handle.net

This paper is made freely available by the publisher.

Francesco Onida, Liesbeth C. de Wreede, Anja van Biezen, Diderik-Jan Eikema, Jenny L. Byrne

ORCID

, Anna P. Iori, Rik Schots, Alexandra Jungova, Johannes Schetelig, Jürgen Finke, Hendrik Veelken, Jan-Erik Johansson, Charles Craddock, Matthias Stelljes, Matthias Theobald and 7 other authors

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Download from api.wiley.com

This paper is made freely available by the publisher.

2016 Ruben Mesa, Alessandro M. Vannucchi, Abdulraheem Yacoub, Pierre Zachee, Mamta Garg, Roger Lyons, Steffen Koschmieder, Ciro Rinaldi, Jennifer Byrne

ORCID

, Yasmin Hasan, Francesco Passamonti, Srdan Verstovsek, Deborah Hunter, Mark M. Jones, Huiling Zhen and 2 other authors

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF)

Download from api.wiley.com

This paper is made freely available by the publisher.

Gordon Cook

ORCID

, Simona Iacobelli, Anja van Biezen, Dimitris Ziagkos, Veronique LeBlond, Julie Abraham, Grant McQuaker, Stefan Schoenland, Niels W. C. J. van de Donk, Alessandro Rambaldi, Kazimierz Halaburda

ORCID

, Maria Rovira, Simona Sica, Jenny Byrne

ORCID

, R. Garcia Sanz and 10 other authors

High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

Download from doi.org

This paper is made freely available by the publisher.

R. R. Pol, N. Russell, E. Das-Gupta, L. Watson, L. Rachael, J. Byrne

ORCID

Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide

Download from www.nature.com

This paper is available in a repository.

Charles Craddock

ORCID

, Nadira Jilani, Shamyla Siddique, Christina Yap

ORCID

, Josephine Khan, Sandeep Nagra, Janice Ward, Paul Ferguson, Peter Hazlewood, Richard Buka, Paresh Vyas, Oliver Goodyear, Eleni Tholouli, Charles Crawley, Nigel Russell and 4 other authors

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Download from www.ncbi.nlm.nih.gov

This paper is made freely available by the publisher.

2014 B. E. Shaw, F. Lee, S. Krishnamurthy, J. L. Byrne

ORCID

, C. Seedhouse, N. P. Mayor, H. Maldonado-Torres, A. Saudemont, S. G. E. Marsh, J. A. Madrigal, N. H. Russell

Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation

Download from www.nature.com

This paper is made freely available by the publisher.

E. Nikolousis, S. Nagra, R. Pearce, J. Perry, K. Kirkland, J. Byrne

ORCID

, F. Dignan, E. Tholouli, M. Gilleece, N. Russell, T. Littlewood, M. Cook, A. Peniket, B. E. Shaw, G. Cook

ORCID

and 1 other authors

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

Victor Noriega, Harpreet Kaur, Stephen Devereux

ORCID

, Jennifer Byrne

ORCID

, Robert Marcus, Andrew Haynes, Deborah Yallop, Andrew McMillan, Wendy Ingram, Anjum Khan, Michelle Kenyon, Victoria Potter, Nigel Russell, Ghulam J. Mufti, Antonio Pagliuca

Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma

Upload

This paper is available in a repository.

Graham H. Jackson, Gareth J. Morgan, Faith E. Davies, Ping Wu, Walter M. Gregory, Sue E. Bell, Alexander J. Szubert, Nuria Navarro Coy, Nuria Navarro Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, Andrew J. Ashcroft, Fiona M. Ross, Jennifer Byrne

ORCID

and 7 other authors

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

Download from www.researchgate.net

This paper is made freely available by the publisher.

2013 Cp P. Fox, D. Burns, An N. Parker, Cm M. Harvey, Ks S. Peggs, S. Natarajan, Di I. Marks, G. Chakupurakal, B. Jackson, Michael Dennis, Z. Lim, G. Cook, B. Carpenter, Ar R. Pettitt, S. Mathew and 10 other authors

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

Download from www.nature.com

Missing publications? Search for publications with a matching author name.